UK-based biopharma Karus Therapeutics has appointed new heads for two of its research divisions.
Dr Simon Roitt joins as head of clinical development and Dr Peter Finan joins as head of biology.
Dr Roitt (pictured right) is formerly director of clinical operations at Roche in the UK, a position he held for nine years. Prior to this he was director of clinical research at GE Healthcare in the UK.
His new colleague Dr Finan joins Karus from Novartis where he spent 16 years. Most recently he was VP, global head – respiratory disease.
In his new role Dr Finan will work on Karus’ most advanced programme, a treatment for inflammatory disorders.
Dr Simon Kerry, chief executive of Karus said: “As we develop the business, the recruitment of highly experienced senior talent to our team will be a critical success factor. Simon and Peter both bring valuable clinical and scientific expertise to the Company, to help drive our programmes towards the clinic.”